Lucile L. Adams-Campbell, PhD, has been appointed Associate Director for Minority Health and Health Disparities Research at Georgetown University Medical Center's Lombardi Comprehensive Cancer Center. Dr. Adams-Campbell is the former Director of the Howard University Cancer Center, and in her new role, she will focus primarily on community outreach and community-based participatory research in Washington, DC.
George Klein, MD, PhD, Professor Emeritus and Research Group Leader for the Microbiology and Tumor Biology Center in Stockholm, Sweden, received the 16th annual Herbert and Maxine Memorial Lectureship award for Achievement in Cancer, given by the James Cancer Hospital and Solove Research Institute at Ohio State University. As part of the recognition, he also delivered the Block Lecture, which he titled “Towards a Genetics of Cancer Resistance.”
Omer Kucuk, MD, has joined Emory University's Winship Cancer Institute as Professor of Hematology and Medical Oncology. Dr. Kucuk comes to Emory from the Karmanos Cancer Center at Wayne State University in Detroit, where he was a professor and co-leader of the population sciences and prevention programs, and a member of the genitourinary and head and neck cancer multidisciplinary groups.
Sheila Bates, Manager of Community Outreach for Vanderbilt-Ingram Cancer Center, has been named the 2008 Health Educator of the Year by the Tennessee Public Health Association, an award given annually to an individual who demonstrates outstanding efforts in the realm of health education and who displays a true passion for helping patients and the public understand the benefits of disease prevention and the latest in treatment advances. Ms. Bates also serves as Colorectal Cancer Resource Committee Chair for the Tennessee Comprehensive Cancer Control Coalition, in dedication to increasing colorectal cancer screening rates, and has also implemented a pilot program providing life coaching to cancer survivors.
The Engelstad Family Foundation has donated $20 million to the Nevada Cancer Institute (NVCI) to further fund the construction of a research facility to be named the Ralph and Betty Engelstad Cancer Research Building. The facility will house 36 individual laboratories for investigators and their teams, as well as a core lab to support clinical research and expand basic and translational research.
“These gifts demonstrate the commitment of the private sector, and a leading foundation, to curing cancer and investing in our state's health care needs,” Nicolas J. Vogelzang, MD, NVCI Director, said in a news release. “This continued support proves that Nevada has the capability to be on the leading edge of important and groundbreaking research. These gifts will resonate for generations.”
The National Institutes of Health has named five cancer researchers as recipients of the 2008 NIH Director's New Innovator Awards: Ronald J. Buckanovich, MD, PhD, University of Michigan Comprehensive Cancer Center; Shelli Kesler, PhD, Stanford University School of Medicine; Sanjay Kumar, MD, PhD, University of California, Berkeley; Ken-ichi Noma, PhD, Wistar Institute; and William M. Shih, PhD, Dana-Farber Cancer Institute. The grants, which will provide $1.5 million over five years, will enable the awardees to pursue innovative approaches that could transform biomedical science.
The Arizona Cancer Center Lymphoma Program in partnership with the University of Rochester James P. Wilmot Cancer Center, have received an $11.5 million Specialized Program of Research Excellence (SPORE) grant from the NCI. The five-year grant will fund translational research projects designed to quickly advance findings from the laboratory to clinical settings and improve care and find cures. The institutions will also be collaborating with researchers from Virginia Commonwealth Massey Cancer Center.
City of Hope has appointed John Hosei Yim, MD, Associate Professor of Surgery. Dr. Yim, who specializes in treating patients with breast and endocrine tumors, joins City of Hope from the University of Pittsburgh's Department of Surgery, where he was an assistant professor of surgery.
Kelli Bullard Dunn, MD, of the Gastrointestinal Service in the Department of Surgical Oncology at Roswell Park Cancer Institute (RPCI) has been awarded the Victor W. Fazio MD, MS, Award for Editorial Excellence by the journal Diseases of the Colon & Rectum. The award, chosen by the editors of the journal, recognizes the reviewer who has done the finest editorial work over the past year.
Also at RPCI, Chukwumere E. Nwogu, MD, Attending Surgeon in the Division of Thoracic Surgery in the Department of Surgery, has been awarded grants from the National Cancer Institute and the Thoracic Surgery Foundation for Research and Education totaling nearly $1.2 million to investigate the effectiveness of an intra-operative gamma probe in the staging of lung cancer. The study will investigate the ability of this probe to intra-operatively identify lymph nodes likely to harbor micrometastases and thereby significantly improve the accuracy of lymph node staging.
Carl June, MD, Director of Translational Research at the Abramson Cancer Center of the University of Pennsylvania and Professor of Pathology and Laboratory Medicine in University of Pennsylvania's School of Medicine, has received the Joan Miller and Linda Bernstein Gene Therapy Ovarian Cancer Award from the Alliance for Cancer Gene Therapy, Inc. The $1 million award to be distributed over the next three years will harness the immune system to fight the worst cases of ovarian cancer in a Phase I clinical trial.
To Reach OT
* Editorial: Oncology Times, 333 Seventh Ave., 19th Fl., New York, NY 10001, 646-674-6529, fax 646-674-6500; e-mail: OT@lwwny.com
* For Circulation Matters: To cancel a subscription, change your address or for other subscription services, please call: 800-430-5450, fax: 800-383-1781, send an e-mail to: firstname.lastname@example.org or send a written request to: Oncology Times, 2340 River Rd., Ste 408, Des Plaines, IL 60019-9883.
* Classifieds: Melissa Moody, Lippincott Williams & Wilkins, 351 West Camden, Baltimore, MD 21201; 800-269-4339; fax 410-528-4452; e-mail: Melissa.Moody@wolterskluwer.com
* Reprints: Patrice Culligan, Pharmaceutical Media Inc, 30 East 33rd St, New York, NY 10016; 212-904-0369; email@example.com
© 2008 Lippincott Williams & Wilkins, Inc.
More on ONCOLOGY-TIMES.com...